Can less anesthesia gas be better for robotic prostate surgery?
NCT ID NCT05517551
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at two ways of giving anesthesia during robotic prostate removal surgery. One method used a low flow of gas (1 liter per minute) and the other used a normal flow (3 liters per minute). The goal was to see which one is better for breathing, heart function, and cost. The study included 68 adults having robotic prostate surgery. Researchers measured oxygen levels, gas use, and other health markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- desflurane
- What this could lead to
- If low-flow anesthesia proves safe and effective, it could become the preferred method for robotic prostatectomies, reducing costs and environmental impact.
- What could go wrong
- This is a small, completed study with only 68 participants. Results may not apply to other surgeries or patient groups. Low-flow anesthesia may not be suitable for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW FLOW ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara City Hospital
Ankara, Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?